To select your language and access country-specific information, click on the relevant flag below.
  • English
  • French
  • Belguim - French
  • Portugal
  • Spanish
  • German
  • Italian
  • Nederlands

The marketing authorisation holder for Myalepta in the EU is Aegerion Pharmaceuticals B.V., Atrium Building, 8th Floor, Strawinskylaan 3127, 1077 ZX Amsterdam, The Netherlands.